All stock lists
Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
Healthcare · Diagnostics & Research
175.63+2.56 (+1.48%)
Insider Score
––Not scored
A Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
A analyst forecast
A analyst consensus
Moderate Buy12 ratings
Buy 12 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
A 12-month price target
$178.40+1.8% upsideaverage of 5 firms
$190.00High
$172.00Low
Best analysts covering A
- Wells Fargo75%success rate · 8 calls
- Goldman Sachs75%success rate · 4 calls
- JP Morgan67%success rate · 6 calls
- Evercore ISI Group67%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
A analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Deutsche Bank | — | $190.00 | +8.0% | — | 2026-10-26 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-10-13 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-07 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-08-28 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-27 |
| — | Stifel | Buy | — | — | Reiterated | 2026-08-27 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-08-27 |
| Goldman Sachs | Buy | $175.00 | +12.8% | Reiterated | 2026-08-27 | |
| Barclays | Overweight | $175.00 | +10.8% | Reiterated | 2026-08-27 | |
| Evercore ISI Group | Outperform | $172.00 | +10.8% | Reiterated | 2026-08-27 | |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-27 |
| — | Bernstein | Outperform | — | — | Reiterated | 2026-08-27 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-27 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-27 |
| Stifel Nicolaus | — | $180.00 | +16.0% | — | 2026-08-27 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-12 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-07-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-06-24 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2026-06-11 |
| — | HSBC | Buy | — | — | Reiterated | 2026-06-03 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-06-02 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-28 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-05-28 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-28 |
| — | B of A Securities | Buy | — | — | Upgraded | 2026-05-28 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-05-28 |
| — | Baird | Outperform | — | — | Reiterated | 2026-05-26 |
| — | Keybanc | Sector Weight | — | — | Reiterated | 2026-04-28 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-14 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-04-13 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-04-06 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-03-03 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-26 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-02-26 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-26 |
| — | UBS | Buy | — | — | Reiterated | 2026-02-26 |
| — | Evercore ISI Group | Outperform | — | — | Upgraded | 2026-01-05 |
| — | Barclays | Overweight | — | — | Upgraded | 2025-12-15 |
| — | Baird | Outperform | — | — | Reiterated | 2025-11-25 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-11-25 |
| — | UBS | Buy | — | — | Reiterated | 2025-11-25 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-11-25 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-11-25 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-11-25 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2025-11-25 |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-10-14 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-09 |
| — | UBS | Buy | — | — | Upgraded | 2025-10-08 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-10-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-10-02 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-09-15 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-08-29 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-08-28 |
| — | Baird | Outperform | — | — | Reiterated | 2025-08-28 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-08-28 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-07-08 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-06-24 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-06-24 |
| — | UBS | Neutral | — | — | Reiterated | 2025-05-29 |
A earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-25 | 1.37 | 1.36 | $1.81B | $1.80B |
| 2026-05-27 | 1.41 | 1.49 | $1.80B | $1.83B |
| 2026-08-26 | 1.49 | 1.62 | $1.84B | $1.88B |
| 2026-11-23 | 1.72 | 0.00 | $1.99B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.